Koesling Doris, Mergia Evanthia, Russwurm Michael
Abteilung für Pharmakologie, Medizinische Fakultät, Ruhr-Universität Bochum, Universitätsstr. 150, 44780 Bochum, Germany.
Curr Med Chem. 2016;23(24):2653-2665. doi: 10.2174/0929867323666160812145050.
NO-sensitive guanylyl cyclase (NO-GC) acts as the receptor for nitric oxide and by the increase in cGMP executes most of the NO effects in the cardiovascular and neuronal system. Two isoforms of NO-GC exist whose existence has not been paid much attention to probably because they reveal comparable regulatory and catalytic properties and therefore cannot be differentiated in vivo. Analysis of mice in which either one of the isoforms has been genetically deleted unequivocally establishes the coexpression of NO-GC1 and NOGC2 in any tissue tested to date with the exception of platelets. In tissues other than brain and platelets, no particular function could be ascribed to a specific NO-GC isoform so far. In contrast, NO-GC1 and NO-GC2 serve different functions in the central nervous system. With NO-GC1s presynaptic role and NO-GC2s postsynaptic action, two NO/cGMP pathways have been shown to exist that enhance the strength of synaptic transmission on either side of the synaptic cleft.
一氧化氮敏感型鸟苷酸环化酶(NO-GC)作为一氧化氮的受体,通过增加环磷酸鸟苷(cGMP)来执行一氧化氮在心血管和神经系统中的大部分作用。存在两种NO-GC亚型,其存在可能未受到太多关注,大概是因为它们表现出相当的调节和催化特性,因此在体内无法区分。对其中一种亚型已被基因敲除的小鼠进行分析,明确证实了迄今为止,除血小板外,在任何测试组织中NO-GC1和NOGC2都是共表达的。到目前为止,在脑和血小板以外的组织中,尚未发现特定的NO-GC亚型具有特定功能。相比之下,NO-GC1和NO-GC2在中枢神经系统中发挥不同功能。NO-GC1具有突触前作用,NO-GC2具有突触后作用,已证明存在两条NO/cGMP途径,它们可增强突触间隙两侧的突触传递强度。